Innovating Works

ASOCIACION INSTITUTO DE INVESTIGACION SA...

Activa
EFFECT: A European Training Program to Foster the Full Therapeutic Potential of Antisense Technology across... "The EFFecT Doctoral Training (DN) Network responds to the evolving landscape of RNA-based therapeutics and in particular antisense oligonuc...
2024-07-05 - 2028-12-31 | Financiado
RadicalProtON: Designing organic molecules as platforms for reversible charge-to-spin conversion with applications... ASOCIACION INSTITUTO DE INVESTIGACION SANITARIA BIOCRUCES BIZKAIA participó en un HORIZON EUROPE ERC-2023-STG Chemistry and Biology are governed by molecules and how they interact. Crucially, what glues a molecule together are chemical bonds, made fr...
2023-11-30 - 2029-05-31 | Financiado
ADRIAN: Multimodal Brain Imaging – Gene Relationships in Alzheimer Disease: Risk and Resilience ASOCIACION INSTITUTO DE INVESTIGACION SANITARIA BIOCRUCES BIZKAIA tramitó un HORIZON EUROPE HORIZON-MSCA-2022-PF-01 The list of genes contributing to increased risk of developing Alzheimer’s Disease (AD) grows every year. To date, large case-control Genome...
2023-04-26 - 2025-09-30 | Financiado
AISym4MED: Synthetic and scalable data platform for medical empowered AI ASOCIACION INSTITUTO DE INVESTIGACION SANITARIA BIOCRUCES BIZKAIA participó en un HORIZON EUROPE HORIZON-HLTH-2022-IND-13 AISym4Med aims at developing a platform that will provide healthcare data engineers, practitioners, and researchers access to a trustworthy...
2022-11-22 - 2026-11-30 | Financiado
SOTERIA: uSer friendly digiTal sEcured peRsonal data and prIvacy plAtform ASOCIACION INSTITUTO DE INVESTIGACION SANITARIA BIOCRUCES BIZKAIA participó en un H2020 H2020-SU-DS-2018-2019-2020 SOTERIA aims to drive a paradigm shift on data protection and enable active participation of citizens to their own security, privacy and per...
2021-04-20 - 2024-09-30 | Financiado
NeoIPC: Establishing innovative approaches for optimal infection prevention of resistant bacteria in NICUs b... ASOCIACION INSTITUTO DE INVESTIGACION SANITARIA BIOCRUCES BIZKAIA participó en un H2020 H2020-SC1-BHC-2018-2020 Around 10% of newborns in Europe will be admitted to a neonatal intensive care unit (NICU). Critically ill babies are a highly vulnerable po...
2021-02-18 - 2026-03-31 | Financiado
GATEKEEPER: SMART LIVING HOMES WHOLE INTERVENTIONS DEMONSTRATOR FOR PEOPLE AT HEALTH AND SOCIAL RISKS ASOCIACION INSTITUTO DE INVESTIGACION SANITARIA BIOCRUCES BIZKAIA participó en un H2020 H2020-SC1-FA-DTS-2018-2020 The main objective of the Project is to create a GATEKEEPER, that connects healthcare providers, businesses, entrepreneurs, elderly citizens...
2019-06-26 - 2023-12-31 | Financiado
TBMED: A testing bed for the development of high risk medical devices ASOCIACION INSTITUTO DE INVESTIGACION SANITARIA BIOCRUCES BIZKAIA participó en un H2020 H2020-NMBP-TO-IND-2018-2020 TBMED will establish an open innovation testing bed specialized in the development of high-risk devices (≥Class IIb). Due to a long reimburs...
2018-12-12 - 2023-08-31 | Financiado
vCare: Virtual Coaching Activities for Rehabilitation in Elderly ASOCIACION INSTITUTO DE INVESTIGACION SANITARIA BIOCRUCES BIZKAIA participó en un H2020 H2020-SC1-2016-2017 One out of six people in the European Union has a disability, usually caused by an acute episode or a chronic disease. Providing a suitable...
2017-08-01 - 2022-08-31 | Financiado
STARR: Decision SupporT and self mAnagement system for stRoke survivoRs ASOCIACION INSTITUTO DE INVESTIGACION SANITARIA BIOCRUCES BIZKAIA participó en un H2020 H2020-PHC-2014-2015 Stroke a leading cause of death and disability, with an estimated total cost of €65 billion per year in Europe. Even though preventive measu...
2015-11-11 - 2019-10-31 | Financiado
CD300sHIV: The CD300 family of receptors in HIV infection ASOCIACION INSTITUTO DE INVESTIGACION SANITARIA BIOCRUCES BIZKAIA tramitó un FP7 This project's main objective is to study the role of the CD300 receptor family in the pathogenesis of the infection by human immunodeficien...
Financiado
IBD-CHARACTER: Inflammatory Bowel Disease CHARACTERization by a multi modal integrated biomarker study ASOCIACION INSTITUTO DE INVESTIGACION SANITARIA BIOCRUCES BIZKAIA participó en un FP7 We propose a collaborative effort to advance our understanding of the inflammatory bowel diseases Ulcerative Colitis and Crohn's Disease and...
Financiado
ECRIN-IA: European Clinical Research Infrastructures Network Integrating Activity ECRIN is a distributed ESFRI-roadmap pan-European infrastructure designed to support multinational clinical research, making Europe a single...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.